GR3007476T3 - - Google Patents

Info

Publication number
GR3007476T3
GR3007476T3 GR930400203T GR930400203T GR3007476T3 GR 3007476 T3 GR3007476 T3 GR 3007476T3 GR 930400203 T GR930400203 T GR 930400203T GR 930400203 T GR930400203 T GR 930400203T GR 3007476 T3 GR3007476 T3 GR 3007476T3
Authority
GR
Greece
Prior art keywords
protein
falciparum
gene
hybridisation
histidine
Prior art date
Application number
GR930400203T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007476T3 publication Critical patent/GR3007476T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR930400203T 1987-11-03 1993-03-26 GR3007476T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873737238 DE3737238A1 (de) 1987-11-03 1987-11-03 Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
GR3007476T3 true GR3007476T3 (el) 1993-07-30

Family

ID=6339664

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400203T GR3007476T3 (el) 1987-11-03 1993-03-26

Country Status (12)

Country Link
US (1) US5393523A (el)
EP (1) EP0315085B1 (el)
JP (1) JPH01165398A (el)
KR (1) KR970009346B1 (el)
AT (1) ATE83928T1 (el)
AU (1) AU618030B2 (el)
DE (2) DE3737238A1 (el)
DK (1) DK610588A (el)
ES (1) ES2037795T3 (el)
FI (1) FI97479C (el)
GR (1) GR3007476T3 (el)
PT (1) PT88915B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474891A1 (en) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains
DE4041836A1 (de) * 1990-12-24 1992-06-25 Behringwerke Ag Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten, ihre herstellung und verwendung
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
EP1754717A1 (en) 2005-08-19 2007-02-21 Université de Lausanne Antigenic peptides and their use
US8556843B2 (en) * 2008-02-02 2013-10-15 AccelDx Blood purification method and apparatus for the treatment of malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW2485A1 (en) * 1984-02-22 1986-09-24 Wellcome Found Cloning of dna for protozoal antigens
AU5603786A (en) * 1985-04-11 1986-10-16 Walter And Eliza Hall Institute Of Medical Research, The Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
US5130416A (en) * 1986-08-13 1992-07-14 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
US4721617A (en) * 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease

Also Published As

Publication number Publication date
ES2037795T3 (es) 1993-07-01
KR890008318A (ko) 1989-07-10
AU618030B2 (en) 1991-12-12
EP0315085A2 (de) 1989-05-10
DK610588A (da) 1989-05-04
DE3737238A1 (de) 1989-05-18
DE3877136D1 (de) 1993-02-11
PT88915A (pt) 1988-12-01
FI97479B (fi) 1996-09-13
FI885023A0 (fi) 1988-11-01
EP0315085B1 (de) 1992-12-30
JPH01165398A (ja) 1989-06-29
ATE83928T1 (de) 1993-01-15
EP0315085A3 (en) 1990-05-02
DK610588D0 (da) 1988-11-02
FI885023A (fi) 1989-05-04
US5393523A (en) 1995-02-28
PT88915B (pt) 1993-01-29
AU2459088A (en) 1989-05-25
KR970009346B1 (en) 1997-06-10
FI97479C (fi) 1996-12-27

Similar Documents

Publication Publication Date Title
CA2123612A1 (en) Hybrid protein between cs from plasmodium and h bsag
DE69009332D1 (de) Magnetisch angetriebene schwingbalkenkraftwandler.
FR2620459B1 (fr) Virus recombinant de la vaccine
IT1229144B (it) Procedimento per la produzione di carbammati.
IT8821082A0 (it) Procedimento per l'imbozzimatura controllata di filato.
GR3007476T3 (el)
DK480685D0 (da) Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum
PT87427A (pt) Arzneimittelkombination zur prophylaxe und therapie von malaria
PH25798A (en) Protein copolymer malaria vaccine
ZA891169B (en) Method for producing a recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
DK36988D0 (da) Ekspression af p.falciparum-circumsporozoitprotein af gaer
AU3763789A (en) Gene encoding 25 kDa surface protein of zygotes and ookinetes of plasmodium
MA22097A1 (fr) Procede de preparation de polypeptide et procede de fabrication d'un vaccin contre le paludisme .
IT1226300B (it) Processo per la preparazione di intermedi per la sintesi del diltiazem.
IT8767645A0 (it) Procedimento per la riduzione di impurezze di resine poliesteri
IT9019723A0 (it) Procedimento per la modificazione di copolimeri di acrilato
IT8920522A0 (it) Procedimento per la produzione di vanadio areni.
IT9048217A0 (it) Procedimento per la produzione di filato
FI886001A (fi) Menetelmä Plasmodium falciparum -proteiinien valmistamiseksi geeniteknisesti ja siinä käyttökelpoisia tuotteita
IT8821479A0 (it) Processo per la preparazione di intermedi per la sintesi del diltiazem.
DE3885735D1 (de) Von einem lebenden körper abgeleitetes protein.
IT9047641A0 (it) Procedimento per la produzione di un filato di fiocco
KR900700599A (ko) 열대열 말라리아 원충의 롭트리(rhoptry)항원
MX13864A (es) Metodo para la produccion de un polipeptido del virus de hepatitis c
IE894106L (en) Expression of the plasmodium circumsporozite protein in¹insects